High Wycombe, United Kingdom

James K Evans

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Laboratories Limited. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James K Evans. Retrieved from https://idiyas.com/inventor/james-k-evans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James K Evans: Innovator in Antifungal Compounds

Introduction

James K Evans is a notable inventor based in High Wycombe, GB. He has made significant contributions to the field of antifungal compounds, particularly through his innovative patent. His work has implications for both medical and agricultural applications.

Latest Patents

James K Evans holds a patent for a compound known as 2-formyloxymethyl-clavam. This compound is described for its use as an antifungal agent against a variety of fungi. The patent details processes for isolating the compound from fermentations of strains of Streptomyces clavuligerus. This innovation is particularly valuable for its potential applications in both medical and horticultural fields.

Career Highlights

Evans is associated with Glaxo Laboratories Limited, where he has been able to apply his expertise in developing antifungal solutions. His work at this esteemed company has allowed him to contribute to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, James K Evans has collaborated with notable colleagues, including Eunice Jean Napier and David Noble. These collaborations have likely enriched his research and contributed to the success of his innovations.

Conclusion

James K Evans is a distinguished inventor whose work in antifungal compounds has made a significant impact in both medical and agricultural sectors. His patent for 2-formyloxymethyl-clavam exemplifies his innovative spirit and dedication to advancing science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…